The global Pemetrexed Drug market is projected to grow from US$ 87 million in 2024 to US$ 117.9 million by 2030, at a Compound Annual Growth Rate (CAGR) of 5.2% during the forecast period.

Pemetrexed Drug Market

Pemetrexed (brand name Alimta) is a chemotherapy drug manufactured and marketed by Eli Lilly and Company. Its indications are the treatment of pleural mesothelioma and non-small cell lung cancer.

Pemetrexed is a chemotherapy drug primarily used for the treatment of certain types of lung cancer and mesothelioma. The global market for Pemetrexed is driven by several factors, including the rising incidence of lung cancer and mesothelioma worldwide. These cancers continue to be major public health concerns, and the demand for effective treatments like Pemetrexed remains high. Additionally, advancements in medical research and technology have led to the development of novel chemotherapy drugs, including Pemetrexed, which have shown promising results in clinical trials. This has further contributed to the demand for Pemetrexed in the global market. Moreover, the increasing healthcare infrastructure and expenditure in emerging economies like China, India, and Brazil have opened up new growth opportunities for Pemetrexed manufacturers. These countries have witnessed a significant rise in the number of cancer cases and are investing in improved healthcare facilities, which is expected to boost the market for Pemetrexed.

Report Covers:

This report presents an overview of global market for Pemetrexed Drug, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Pemetrexed Drug, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Pemetrexed Drug, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Pemetrexed Drug sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Pemetrexed Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Pemetrexed Drug sales, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Pemetrexed Drug Market Report

Report Metric	Details
Report Name	Pemetrexed Drug Market
Accounted market size in 2024	US$ 87 million
Forecasted market size in 2030	US$ 117.9 million
CAGR	5.2
Base Year	2024
Forecasted years	2025 - 2030
Segment by Type	100 mg lyophilized powder/vial 500 mg lyophilized powder/vial
Segment by Application	Pleural mesothelioma Non-small cell lung cancer
Segment by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Teva, Eagle Pharmaceuticals, APOTEX, Qilu Pharmaceutical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Pemetrexed Drug in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Pemetrexed Drug manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pemetrexed Drug sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

FAQ for this report

How fast is Pemetrexed Drug Market growing?

Ans: The Pemetrexed Drug Market witnessing a CAGR of 5.2 during the forecast period 2025-2030.

What is the Pemetrexed Drug Market size in 2030?

Ans: The Pemetrexed Drug Market size in 2030 will be US$ 117.9 million.

Who are the main players in the Pemetrexed Drug Market report?

Ans: The main players in the Pemetrexed Drug Market are Teva, Eagle Pharmaceuticals, APOTEX, Qilu Pharmaceutical

What are the Application segmentation covered in the Pemetrexed Drug Market report?

Ans: The Applications covered in the Pemetrexed Drug Market report are Pleural mesothelioma, Non-small cell lung cancer

What are the Type segmentation covered in the Pemetrexed Drug Market report?

Ans: The Types covered in the Pemetrexed Drug Market report are 100 mg lyophilized powder/vial, 500 mg lyophilized powder/vial

1 Study Coverage

1.1 Pemetrexed Drug Product Introduction

1.2 Market by Type

1.2.1 Global Pemetrexed Drug Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 100 mg lyophilized powder/vial

1.2.3 500 mg lyophilized powder/vial

1.3 Market by Application

1.3.1 Global Pemetrexed Drug Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Pleural mesothelioma

1.3.3 Non-small cell lung cancer

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Pemetrexed Drug Sales Estimates and Forecasts 2019-2030

2.2 Global Pemetrexed Drug Revenue by Region

2.2.1 Global Pemetrexed Drug Revenue by Region: 2019 VS 2023 VS 2030

2.2.2 Global Pemetrexed Drug Revenue by Region (2019-2024)

2.2.3 Global Pemetrexed Drug Revenue by Region (2025-2030)

2.2.4 Global Pemetrexed Drug Revenue Market Share by Region (2019-2030)

2.3 Global Pemetrexed Drug Sales Estimates and Forecasts 2019-2030

2.4 Global Pemetrexed Drug Sales by Region

2.4.1 Global Pemetrexed Drug Sales by Region: 2019 VS 2023 VS 2030

2.4.2 Global Pemetrexed Drug Sales by Region (2019-2024)

2.4.3 Global Pemetrexed Drug Sales by Region (2025-2030)

2.4.4 Global Pemetrexed Drug Sales Market Share by Region (2019-2030)

2.5 US & Canada

2.6 Europe

2.7 China

2.8 Asia (excluding China)

2.9 Middle East, Africa and Latin America

3 Competition by Manufactures

3.1 Global Pemetrexed Drug Sales by Manufacturers

3.1.1 Global Pemetrexed Drug Sales by Manufacturers (2019-2024)

3.1.2 Global Pemetrexed Drug Sales Market Share by Manufacturers (2019-2024)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Pemetrexed Drug in 2023

3.2 Global Pemetrexed Drug Revenue by Manufacturers

3.2.1 Global Pemetrexed Drug Revenue by Manufacturers (2019-2024)

3.2.2 Global Pemetrexed Drug Revenue Market Share by Manufacturers (2019-2024)

3.2.3 Global Top 10 and Top 5 Companies by Pemetrexed Drug Revenue in 2023

3.3 Global Key Players of Pemetrexed Drug, Industry Ranking, 2022 VS 2023 VS 2024

3.4 Global Pemetrexed Drug Sales Price by Manufacturers

3.5 Analysis of Competitive Landscape

3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.5.2 Global Pemetrexed Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.6 Global Key Manufacturers of Pemetrexed Drug, Manufacturing Base Distribution and Headquarters

3.7 Global Key Manufacturers of Pemetrexed Drug, Product Offered and Application

3.8 Global Key Manufacturers of Pemetrexed Drug, Date of Enter into This Industry

3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global Pemetrexed Drug Sales by Type

4.1.1 Global Pemetrexed Drug Historical Sales by Type (2019-2024)

4.1.2 Global Pemetrexed Drug Forecasted Sales by Type (2025-2030)

4.1.3 Global Pemetrexed Drug Sales Market Share by Type (2019-2030)

4.2 Global Pemetrexed Drug Revenue by Type

4.2.1 Global Pemetrexed Drug Historical Revenue by Type (2019-2024)

4.2.2 Global Pemetrexed Drug Forecasted Revenue by Type (2025-2030)

4.2.3 Global Pemetrexed Drug Revenue Market Share by Type (2019-2030)

4.3 Global Pemetrexed Drug Price by Type

4.3.1 Global Pemetrexed Drug Price by Type (2019-2024)

4.3.2 Global Pemetrexed Drug Price Forecast by Type (2025-2030)

5 Market Size by Application

5.1 Global Pemetrexed Drug Sales by Application

5.1.1 Global Pemetrexed Drug Historical Sales by Application (2019-2024)

5.1.2 Global Pemetrexed Drug Forecasted Sales by Application (2025-2030)

5.1.3 Global Pemetrexed Drug Sales Market Share by Application (2019-2030)

5.2 Global Pemetrexed Drug Revenue by Application

5.2.1 Global Pemetrexed Drug Historical Revenue by Application (2019-2024)

5.2.2 Global Pemetrexed Drug Forecasted Revenue by Application (2025-2030)

5.2.3 Global Pemetrexed Drug Revenue Market Share by Application (2019-2030)

5.3 Global Pemetrexed Drug Price by Application

5.3.1 Global Pemetrexed Drug Price by Application (2019-2024)

5.3.2 Global Pemetrexed Drug Price Forecast by Application (2025-2030)

6 US & Canada

6.1 US & Canada Pemetrexed Drug Market Size by Type

6.1.1 US & Canada Pemetrexed Drug Sales by Type (2019-2030)

6.1.2 US & Canada Pemetrexed Drug Revenue by Type (2019-2030)

6.2 US & Canada Pemetrexed Drug Market Size by Application

6.2.1 US & Canada Pemetrexed Drug Sales by Application (2019-2030)

6.2.2 US & Canada Pemetrexed Drug Revenue by Application (2019-2030)

6.3 US & Canada Pemetrexed Drug Market Size by Country

6.3.1 US & Canada Pemetrexed Drug Revenue by Country: 2019 VS 2023 VS 2030

6.3.2 US & Canada Pemetrexed Drug Sales by Country (2019-2030)

6.3.3 US & Canada Pemetrexed Drug Revenue by Country (2019-2030)

6.3.4 US

6.3.5 Canada

7 Europe

7.1 Europe Pemetrexed Drug Market Size by Type

7.1.1 Europe Pemetrexed Drug Sales by Type (2019-2030)

7.1.2 Europe Pemetrexed Drug Revenue by Type (2019-2030)

7.2 Europe Pemetrexed Drug Market Size by Application

7.2.1 Europe Pemetrexed Drug Sales by Application (2019-2030)

7.2.2 Europe Pemetrexed Drug Revenue by Application (2019-2030)

7.3 Europe Pemetrexed Drug Market Size by Country

7.3.1 Europe Pemetrexed Drug Revenue by Country: 2019 VS 2023 VS 2030

7.3.2 Europe Pemetrexed Drug Sales by Country (2019-2030)

7.3.3 Europe Pemetrexed Drug Revenue by Country (2019-2030)

7.3.4 Germany

7.3.5 France

7.3.6 U.K.

7.3.7 Italy

7.3.8 Russia

8 China

8.1 China Pemetrexed Drug Market Size

8.1.1 China Pemetrexed Drug Sales (2019-2030)

8.1.2 China Pemetrexed Drug Revenue (2019-2030)

8.2 China Pemetrexed Drug Market Size by Application

8.2.1 China Pemetrexed Drug Sales by Application (2019-2030)

8.2.2 China Pemetrexed Drug Revenue by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Pemetrexed Drug Market Size by Type

9.1.1 Asia Pemetrexed Drug Sales by Type (2019-2030)

9.1.2 Asia Pemetrexed Drug Revenue by Type (2019-2030)

9.2 Asia Pemetrexed Drug Market Size by Application

9.2.1 Asia Pemetrexed Drug Sales by Application (2019-2030)

9.2.2 Asia Pemetrexed Drug Revenue by Application (2019-2030)

9.3 Asia Pemetrexed Drug Sales by Region

9.3.1 Asia Pemetrexed Drug Revenue by Region: 2019 VS 2023 VS 2030

9.3.2 Asia Pemetrexed Drug Revenue by Region (2019-2030)

9.3.3 Asia Pemetrexed Drug Sales by Region (2019-2030)

9.3.4 Japan

9.3.5 South Korea

9.3.6 China Taiwan

9.3.7 Southeast Asia

9.3.8 India

10 Middle East, Africa and Latin America

10.1 Middle East, Africa and Latin America Pemetrexed Drug Market Size by Type

10.1.1 Middle East, Africa and Latin America Pemetrexed Drug Sales by Type (2019-2030)

10.1.2 Middle East, Africa and Latin America Pemetrexed Drug Revenue by Type (2019-2030)

10.2 Middle East, Africa and Latin America Pemetrexed Drug Market Size by Application

10.2.1 Middle East, Africa and Latin America Pemetrexed Drug Sales by Application (2019-2030)

10.2.2 Middle East, Africa and Latin America Pemetrexed Drug Revenue by Application (2019-2030)

10.3 Middle East, Africa and Latin America Pemetrexed Drug Sales by Country

10.3.1 Middle East, Africa and Latin America Pemetrexed Drug Revenue by Country: 2019 VS 2023 VS 2030

10.3.2 Middle East, Africa and Latin America Pemetrexed Drug Revenue by Country (2019-2030)

10.3.3 Middle East, Africa and Latin America Pemetrexed Drug Sales by Country (2019-2030)

10.3.4 Brazil

10.3.5 Mexico

10.3.6 Turkey

10.3.7 Israel

10.3.8 GCC Countries

11 Company Profiles

11.1 Eli Lilly and Company

11.1.1 Eli Lilly and Company Company Information

11.1.2 Eli Lilly and Company Overview

11.1.3 Eli Lilly and Company Pemetrexed Drug Sales, Price, Revenue and Gross Margin (2019-2024)

11.1.4 Eli Lilly and Company Pemetrexed Drug Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 Eli Lilly and Company Recent Developments

11.2 Pfizer

11.2.1 Pfizer Company Information

11.2.2 Pfizer Overview

11.2.3 Pfizer Pemetrexed Drug Sales, Price, Revenue and Gross Margin (2019-2024)

11.2.4 Pfizer Pemetrexed Drug Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 Pfizer Recent Developments

11.3 Teva

11.3.1 Teva Company Information

11.3.2 Teva Overview

11.3.3 Teva Pemetrexed Drug Sales, Price, Revenue and Gross Margin (2019-2024)

11.3.4 Teva Pemetrexed Drug Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 Teva Recent Developments

11.4 Eagle Pharmaceuticals

11.4.1 Eagle Pharmaceuticals Company Information

11.4.2 Eagle Pharmaceuticals Overview

11.4.3 Eagle Pharmaceuticals Pemetrexed Drug Sales, Price, Revenue and Gross Margin (2019-2024)

11.4.4 Eagle Pharmaceuticals Pemetrexed Drug Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 Eagle Pharmaceuticals Recent Developments

11.5 APOTEX

11.5.1 APOTEX Company Information

11.5.2 APOTEX Overview

11.5.3 APOTEX Pemetrexed Drug Sales, Price, Revenue and Gross Margin (2019-2024)

11.5.4 APOTEX Pemetrexed Drug Product Model Numbers, Pictures, Descriptions and Specifications

11.5.5 APOTEX Recent Developments

11.6 Qilu Pharmaceutical

11.6.1 Qilu Pharmaceutical Company Information

11.6.2 Qilu Pharmaceutical Overview

11.6.3 Qilu Pharmaceutical Pemetrexed Drug Sales, Price, Revenue and Gross Margin (2019-2024)

11.6.4 Qilu Pharmaceutical Pemetrexed Drug Product Model Numbers, Pictures, Descriptions and Specifications

11.6.5 Qilu Pharmaceutical Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Pemetrexed Drug Industry Chain Analysis

12.2 Pemetrexed Drug Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Pemetrexed Drug Production Mode & Process

12.4 Pemetrexed Drug Sales and Marketing

12.4.1 Pemetrexed Drug Sales Channels

12.4.2 Pemetrexed Drug Distributors

12.5 Pemetrexed Drug Customers

13 Market Dynamics

13.1 Pemetrexed Drug Industry Trends

13.2 Pemetrexed Drug Market Drivers

13.3 Pemetrexed Drug Market Challenges

13.4 Pemetrexed Drug Market Restraints

14 Key Findings in The Global Pemetrexed Drug Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

FEATURED COMPANIES

Pfizer Inc

TEVA

Eagle Pharmaceuticals

Apotex

Qilu Pharmaceutical

Eli Lilly and Company

List of Tables

Table 1. Global Pemetrexed Drug Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Table 2. Major Manufacturers of 100 mg lyophilized powder/vial

Table 3. Major Manufacturers of 500 mg lyophilized powder/vial

Table 4. Global Pemetrexed Drug Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Table 5. Global Pemetrexed Drug Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 6. Global Pemetrexed Drug Revenue by Region (2019-2024) & (US$ Million)

Table 7. Global Pemetrexed Drug Revenue by Region (2025-2030) & (US$ Million)

Table 8. Global Pemetrexed Drug Revenue Market Share by Region (2019-2024)

Table 9. Global Pemetrexed Drug Revenue Market Share by Region (2025-2030)

Table 10. Global Pemetrexed Drug Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 11. Global Pemetrexed Drug Sales by Region (2019-2024) & (K Units)

Table 12. Global Pemetrexed Drug Sales by Region (2025-2030) & (K Units)

Table 13. Global Pemetrexed Drug Sales Market Share by Region (2019-2024)

Table 14. Global Pemetrexed Drug Sales Market Share by Region (2025-2030)

Table 15. Global Pemetrexed Drug Sales by Manufacturers (2019-2024) & (K Units)

Table 16. Global Pemetrexed Drug Sales Share by Manufacturers (2019-2024)

Table 17. Global Pemetrexed Drug Revenue by Manufacturers (2019-2024) & (US$ Million)

Table 18. Global Pemetrexed Drug Revenue Share by Manufacturers (2019-2024)

Table 19. Global Key Players of Pemetrexed Drug, Industry Ranking, 2022 VS 2023 VS 2024

Table 20. Pemetrexed Drug Price by Manufacturers 2019-2024 (USD/Unit)

Table 21. Global Pemetrexed Drug Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 22. Global Pemetrexed Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pemetrexed Drug as of 2023)

Table 23. Global Key Manufacturers of Pemetrexed Drug, Manufacturing Base Distribution and Headquarters

Table 24. Global Key Manufacturers of Pemetrexed Drug, Product Offered and Application

Table 25. Global Key Manufacturers of Pemetrexed Drug, Date of Enter into This Industry

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. Global Pemetrexed Drug Sales by Type (2019-2024) & (K Units)

Table 28. Global Pemetrexed Drug Sales by Type (2025-2030) & (K Units)

Table 29. Global Pemetrexed Drug Sales Share by Type (2019-2024)

Table 30. Global Pemetrexed Drug Sales Share by Type (2025-2030)

Table 31. Global Pemetrexed Drug Revenue by Type (2019-2024) & (US$ Million)

Table 32. Global Pemetrexed Drug Revenue by Type (2025-2030) & (US$ Million)

Table 33. Global Pemetrexed Drug Revenue Share by Type (2019-2024)

Table 34. Global Pemetrexed Drug Revenue Share by Type (2025-2030)

Table 35. Pemetrexed Drug Price by Type (2019-2024) & (USD/Unit)

Table 36. Global Pemetrexed Drug Price Forecast by Type (2025-2030) & (USD/Unit)

Table 37. Global Pemetrexed Drug Sales by Application (2019-2024) & (K Units)

Table 38. Global Pemetrexed Drug Sales by Application (2025-2030) & (K Units)

Table 39. Global Pemetrexed Drug Sales Share by Application (2019-2024)

Table 40. Global Pemetrexed Drug Sales Share by Application (2025-2030)

Table 41. Global Pemetrexed Drug Revenue by Application (2019-2024) & (US$ Million)

Table 42. Global Pemetrexed Drug Revenue by Application (2025-2030) & (US$ Million)

Table 43. Global Pemetrexed Drug Revenue Share by Application (2019-2024)

Table 44. Global Pemetrexed Drug Revenue Share by Application (2025-2030)

Table 45. Pemetrexed Drug Price by Application (2019-2024) & (USD/Unit)

Table 46. Global Pemetrexed Drug Price Forecast by Application (2025-2030) & (USD/Unit)

Table 47. US & Canada Pemetrexed Drug Sales by Type (2019-2024) & (K Units)

Table 48. US & Canada Pemetrexed Drug Sales by Type (2025-2030) & (K Units)

Table 49. US & Canada Pemetrexed Drug Revenue by Type (2019-2024) & (US$ Million)

Table 50. US & Canada Pemetrexed Drug Revenue by Type (2025-2030) & (US$ Million)

Table 51. US & Canada Pemetrexed Drug Sales by Application (2019-2024) & (K Units)

Table 52. US & Canada Pemetrexed Drug Sales by Application (2025-2030) & (K Units)

Table 53. US & Canada Pemetrexed Drug Revenue by Application (2019-2024) & (US$ Million)

Table 54. US & Canada Pemetrexed Drug Revenue by Application (2025-2030) & (US$ Million)

Table 55. US & Canada Pemetrexed Drug Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 56. US & Canada Pemetrexed Drug Revenue by Country (2019-2024) & (US$ Million)

Table 57. US & Canada Pemetrexed Drug Revenue by Country (2025-2030) & (US$ Million)

Table 58. US & Canada Pemetrexed Drug Sales by Country (2019-2024) & (K Units)

Table 59. US & Canada Pemetrexed Drug Sales by Country (2025-2030) & (K Units)

Table 60. Europe Pemetrexed Drug Sales by Type (2019-2024) & (K Units)

Table 61. Europe Pemetrexed Drug Sales by Type (2025-2030) & (K Units)

Table 62. Europe Pemetrexed Drug Revenue by Type (2019-2024) & (US$ Million)

Table 63. Europe Pemetrexed Drug Revenue by Type (2025-2030) & (US$ Million)

Table 64. Europe Pemetrexed Drug Sales by Application (2019-2024) & (K Units)

Table 65. Europe Pemetrexed Drug Sales by Application (2025-2030) & (K Units)

Table 66. Europe Pemetrexed Drug Revenue by Application (2019-2024) & (US$ Million)

Table 67. Europe Pemetrexed Drug Revenue by Application (2025-2030) & (US$ Million)

Table 68. Europe Pemetrexed Drug Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 69. Europe Pemetrexed Drug Revenue by Country (2019-2024) & (US$ Million)

Table 70. Europe Pemetrexed Drug Revenue by Country (2025-2030) & (US$ Million)

Table 71. Europe Pemetrexed Drug Sales by Country (2019-2024) & (K Units)

Table 72. Europe Pemetrexed Drug Sales by Country (2025-2030) & (K Units)

Table 73. China Pemetrexed Drug Sales by Type (2019-2024) & (K Units)

Table 74. China Pemetrexed Drug Sales by Type (2025-2030) & (K Units)

Table 75. China Pemetrexed Drug Revenue by Type (2019-2024) & (US$ Million)

Table 76. China Pemetrexed Drug Revenue by Type (2025-2030) & (US$ Million)

Table 77. China Pemetrexed Drug Sales by Application (2019-2024) & (K Units)

Table 78. China Pemetrexed Drug Sales by Application (2025-2030) & (K Units)

Table 79. China Pemetrexed Drug Revenue by Application (2019-2024) & (US$ Million)

Table 80. China Pemetrexed Drug Revenue by Application (2025-2030) & (US$ Million)

Table 81. Asia Pemetrexed Drug Sales by Type (2019-2024) & (K Units)

Table 82. Asia Pemetrexed Drug Sales by Type (2025-2030) & (K Units)

Table 83. Asia Pemetrexed Drug Revenue by Type (2019-2024) & (US$ Million)

Table 84. Asia Pemetrexed Drug Revenue by Type (2025-2030) & (US$ Million)

Table 85. Asia Pemetrexed Drug Sales by Application (2019-2024) & (K Units)

Table 86. Asia Pemetrexed Drug Sales by Application (2025-2030) & (K Units)

Table 87. Asia Pemetrexed Drug Revenue by Application (2019-2024) & (US$ Million)

Table 88. Asia Pemetrexed Drug Revenue by Application (2025-2030) & (US$ Million)

Table 89. Asia Pemetrexed Drug Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 90. Asia Pemetrexed Drug Revenue by Region (2019-2024) & (US$ Million)

Table 91. Asia Pemetrexed Drug Revenue by Region (2025-2030) & (US$ Million)

Table 92. Asia Pemetrexed Drug Sales by Region (2019-2024) & (K Units)

Table 93. Asia Pemetrexed Drug Sales by Region (2025-2030) & (K Units)

Table 94. Middle East, Africa and Latin America Pemetrexed Drug Sales by Type (2019-2024) & (K Units)

Table 95. Middle East, Africa and Latin America Pemetrexed Drug Sales by Type (2025-2030) & (K Units)

Table 96. Middle East, Africa and Latin America Pemetrexed Drug Revenue by Type (2019-2024) & (US$ Million)

Table 97. Middle East, Africa and Latin America Pemetrexed Drug Revenue by Type (2025-2030) & (US$ Million)

Table 98. Middle East, Africa and Latin America Pemetrexed Drug Sales by Application (2019-2024) & (K Units)

Table 99. Middle East, Africa and Latin America Pemetrexed Drug Sales by Application (2025-2030) & (K Units)

Table 100. Middle East, Africa and Latin America Pemetrexed Drug Revenue by Application (2019-2024) & (US$ Million)

Table 101. Middle East, Africa and Latin America Pemetrexed Drug Revenue by Application (2025-2030) & (US$ Million)

Table 102. Middle East, Africa and Latin America Pemetrexed Drug Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 103. Middle East, Africa and Latin America Pemetrexed Drug Revenue by Country (2019-2024) & (US$ Million)

Table 104. Middle East, Africa and Latin America Pemetrexed Drug Revenue by Country (2025-2030) & (US$ Million)

Table 105. Middle East, Africa and Latin America Pemetrexed Drug Sales by Country (2019-2024) & (K Units)

Table 106. Middle East, Africa and Latin America Pemetrexed Drug Sales by Country (2025-2030) & (K Units)

Table 107. Eli Lilly and Company Company Information

Table 108. Eli Lilly and Company Description and Major Businesses

Table 109. Eli Lilly and Company Pemetrexed Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 110. Eli Lilly and Company Pemetrexed Drug Product Model Numbers, Pictures, Descriptions and Specifications

Table 111. Eli Lilly and Company Recent Developments

Table 112. Pfizer Company Information

Table 113. Pfizer Description and Major Businesses

Table 114. Pfizer Pemetrexed Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 115. Pfizer Pemetrexed Drug Product Model Numbers, Pictures, Descriptions and Specifications

Table 116. Pfizer Recent Developments

Table 117. Teva Company Information

Table 118. Teva Description and Major Businesses

Table 119. Teva Pemetrexed Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 120. Teva Pemetrexed Drug Product Model Numbers, Pictures, Descriptions and Specifications

Table 121. Teva Recent Developments

Table 122. Eagle Pharmaceuticals Company Information

Table 123. Eagle Pharmaceuticals Description and Major Businesses

Table 124. Eagle Pharmaceuticals Pemetrexed Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 125. Eagle Pharmaceuticals Pemetrexed Drug Product Model Numbers, Pictures, Descriptions and Specifications

Table 126. Eagle Pharmaceuticals Recent Developments

Table 127. APOTEX Company Information

Table 128. APOTEX Description and Major Businesses

Table 129. APOTEX Pemetrexed Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 130. APOTEX Pemetrexed Drug Product Model Numbers, Pictures, Descriptions and Specifications

Table 131. APOTEX Recent Developments

Table 132. Qilu Pharmaceutical Company Information

Table 133. Qilu Pharmaceutical Description and Major Businesses

Table 134. Qilu Pharmaceutical Pemetrexed Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 135. Qilu Pharmaceutical Pemetrexed Drug Product Model Numbers, Pictures, Descriptions and Specifications

Table 136. Qilu Pharmaceutical Recent Developments

Table 137. Key Raw Materials Lists

Table 138. Raw Materials Key Suppliers Lists

Table 139. Pemetrexed Drug Distributors List

Table 140. Pemetrexed Drug Customers List

Table 141. Pemetrexed Drug Market Trends

Table 142. Pemetrexed Drug Market Drivers

Table 143. Pemetrexed Drug Market Challenges

Table 144. Pemetrexed Drug Market Restraints

Table 145. Research Programs/Design for This Report

Table 146. Key Data Information from Secondary Sources

Table 147. Key Data Information from Primary Sources

List of Figures

Figure 1. Pemetrexed Drug Product Picture

Figure 2. Global Pemetrexed Drug Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Pemetrexed Drug Market Share by Type in 2023 & 2030

Figure 4. 100 mg lyophilized powder/vial Product Picture

Figure 5. 500 mg lyophilized powder/vial Product Picture

Figure 6. Global Pemetrexed Drug Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 7. Global Pemetrexed Drug Market Share by Application in 2023 & 2030

Figure 8. Pleural mesothelioma

Figure 9. Non-small cell lung cancer

Figure 10. Pemetrexed Drug Report Years Considered

Figure 11. Global Pemetrexed Drug Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 12. Global Pemetrexed Drug Revenue 2019-2030 (US$ Million)

Figure 13. Global Pemetrexed Drug Revenue Market Share by Region in Percentage: 2023 Versus 2030

Figure 14. Global Pemetrexed Drug Revenue Market Share by Region (2019-2030)

Figure 15. Global Pemetrexed Drug Sales 2019-2030 ((K Units)

Figure 16. Global Pemetrexed Drug Sales Market Share by Region (2019-2030)

Figure 17. US & Canada Pemetrexed Drug Sales YoY (2019-2030) & (K Units)

Figure 18. US & Canada Pemetrexed Drug Revenue YoY (2019-2030) & (US$ Million)

Figure 19. Europe Pemetrexed Drug Sales YoY (2019-2030) & (K Units)

Figure 20. Europe Pemetrexed Drug Revenue YoY (2019-2030) & (US$ Million)

Figure 21. China Pemetrexed Drug Sales YoY (2019-2030) & (K Units)

Figure 22. China Pemetrexed Drug Revenue YoY (2019-2030) & (US$ Million)

Figure 23. Asia (excluding China) Pemetrexed Drug Sales YoY (2019-2030) & (K Units)

Figure 24. Asia (excluding China) Pemetrexed Drug Revenue YoY (2019-2030) & (US$ Million)

Figure 25. Middle East, Africa and Latin America Pemetrexed Drug Sales YoY (2019-2030) & (K Units)

Figure 26. Middle East, Africa and Latin America Pemetrexed Drug Revenue YoY (2019-2030) & (US$ Million)

Figure 27. The Pemetrexed Drug Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023

Figure 28. The Top 5 and 10 Largest Manufacturers of Pemetrexed Drug in the World: Market Share by Pemetrexed Drug Revenue in 2023

Figure 29. Global Pemetrexed Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 30. Global Pemetrexed Drug Sales Market Share by Type (2019-2030)

Figure 31. Global Pemetrexed Drug Revenue Market Share by Type (2019-2030)

Figure 32. Global Pemetrexed Drug Sales Market Share by Application (2019-2030)

Figure 33. Global Pemetrexed Drug Revenue Market Share by Application (2019-2030)

Figure 34. US & Canada Pemetrexed Drug Sales Market Share by Type (2019-2030)

Figure 35. US & Canada Pemetrexed Drug Revenue Market Share by Type (2019-2030)

Figure 36. US & Canada Pemetrexed Drug Sales Market Share by Application (2019-2030)

Figure 37. US & Canada Pemetrexed Drug Revenue Market Share by Application (2019-2030)

Figure 38. US & Canada Pemetrexed Drug Revenue Share by Country (2019-2030)

Figure 39. US & Canada Pemetrexed Drug Sales Share by Country (2019-2030)

Figure 40. U.S. Pemetrexed Drug Revenue (2019-2030) & (US$ Million)

Figure 41. Canada Pemetrexed Drug Revenue (2019-2030) & (US$ Million)

Figure 42. Europe Pemetrexed Drug Sales Market Share by Type (2019-2030)

Figure 43. Europe Pemetrexed Drug Revenue Market Share by Type (2019-2030)

Figure 44. Europe Pemetrexed Drug Sales Market Share by Application (2019-2030)

Figure 45. Europe Pemetrexed Drug Revenue Market Share by Application (2019-2030)

Figure 46. Europe Pemetrexed Drug Revenue Share by Country (2019-2030)

Figure 47. Europe Pemetrexed Drug Sales Share by Country (2019-2030)

Figure 48. Germany Pemetrexed Drug Revenue (2019-2030) & (US$ Million)

Figure 49. France Pemetrexed Drug Revenue (2019-2030) & (US$ Million)

Figure 50. U.K. Pemetrexed Drug Revenue (2019-2030) & (US$ Million)

Figure 51. Italy Pemetrexed Drug Revenue (2019-2030) & (US$ Million)

Figure 52. Russia Pemetrexed Drug Revenue (2019-2030) & (US$ Million)

Figure 53. China Pemetrexed Drug Sales Market Share by Type (2019-2030)

Figure 54. China Pemetrexed Drug Revenue Market Share by Type (2019-2030)

Figure 55. China Pemetrexed Drug Sales Market Share by Application (2019-2030)

Figure 56. China Pemetrexed Drug Revenue Market Share by Application (2019-2030)

Figure 57. Asia Pemetrexed Drug Sales Market Share by Type (2019-2030)

Figure 58. Asia Pemetrexed Drug Revenue Market Share by Type (2019-2030)

Figure 59. Asia Pemetrexed Drug Sales Market Share by Application (2019-2030)

Figure 60. Asia Pemetrexed Drug Revenue Market Share by Application (2019-2030)

Figure 61. Asia Pemetrexed Drug Revenue Share by Region (2019-2030)

Figure 62. Asia Pemetrexed Drug Sales Share by Region (2019-2030)

Figure 63. Japan Pemetrexed Drug Revenue (2019-2030) & (US$ Million)

Figure 64. South Korea Pemetrexed Drug Revenue (2019-2030) & (US$ Million)

Figure 65. China Taiwan Pemetrexed Drug Revenue (2019-2030) & (US$ Million)

Figure 66. Southeast Asia Pemetrexed Drug Revenue (2019-2030) & (US$ Million)

Figure 67. India Pemetrexed Drug Revenue (2019-2030) & (US$ Million)

Figure 68. Middle East, Africa and Latin America Pemetrexed Drug Sales Market Share by Type (2019-2030)

Figure 69. Middle East, Africa and Latin America Pemetrexed Drug Revenue Market Share by Type (2019-2030)

Figure 70. Middle East, Africa and Latin America Pemetrexed Drug Sales Market Share by Application (2019-2030)

Figure 71. Middle East, Africa and Latin America Pemetrexed Drug Revenue Market Share by Application (2019-2030)

Figure 72. Middle East, Africa and Latin America Pemetrexed Drug Revenue Share by Country (2019-2030)

Figure 73. Middle East, Africa and Latin America Pemetrexed Drug Sales Share by Country (2019-2030)

Figure 74. Brazil Pemetrexed Drug Revenue (2019-2030) & (US$ Million)

Figure 75. Mexico Pemetrexed Drug Revenue (2019-2030) & (US$ Million)

Figure 76. Turkey Pemetrexed Drug Revenue (2019-2030) & (US$ Million)

Figure 77. Israel Pemetrexed Drug Revenue (2019-2030) & (US$ Million)

Figure 78. GCC Countries Pemetrexed Drug Revenue (2019-2030) & (US$ Million)

Figure 79. Pemetrexed Drug Value Chain

Figure 80. Pemetrexed Drug Production Process

Figure 81. Channels of Distribution

Figure 82. Distributors Profiles

Figure 83. Bottom-up and Top-down Approaches for This Report

Figure 84. Data Triangulation

Figure 85. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions